Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 49

Results For "Vice-President"

1007 News Found

Sonam Kapoor launches new range of  pregnancy care solution for Prega News
Healthcare | September 12, 2023

Sonam Kapoor launches new range of pregnancy care solution for Prega News

The brand has launched 6 new range of products to provide a complete pregnancy care solution


USFDA approves BMS’ Reblozyl as first-line treatment of anemia in adults with Myelodysplastic Syndromes
Drug Approval | September 01, 2023

USFDA approves BMS’ Reblozyl as first-line treatment of anemia in adults with Myelodysplastic Syndromes

Reblozyl is the first and only therapy to demonstrate superiority compared to an erythropoiesis stimulating agent (ESA) in MDS-related anemia


European Commission approves Keytruda plus Trastuzumab and chemotherapy as first-line treatment for GEJ
Drug Approval | August 30, 2023

European Commission approves Keytruda plus Trastuzumab and chemotherapy as first-line treatment for GEJ

KEYTRUDA is the first immunotherapy approved in the EU for the first-line treatment of this patient population


CK Birla Hospital signs MoU Intuitive for robotic-assisted surgery
Medical Device | August 30, 2023

CK Birla Hospital signs MoU Intuitive for robotic-assisted surgery

Hospital joins with Intuitive to install da Vinci systems to support enhanced healthcare delivery and patient outcomes across India


BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint
Clinical Trials | August 29, 2023

BlueRock’s Phase I study with bemdaneprocel in patients with Parkinson’s disease meets primary endpoint

Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year


Lynparza plus abi/pred approved in Japan for treatment of prostate cancer
Drug Approval | August 25, 2023

Lynparza plus abi/pred approved in Japan for treatment of prostate cancer

First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent


Intuitive and Max Healthcare to launch TPO Centre for robotic-assisted surgery
News | August 25, 2023

Intuitive and Max Healthcare to launch TPO Centre for robotic-assisted surgery

Centre aims to train surgeons and other healthcare professionals from India and Southeast Asia in robotic-assisted surgery


EMA accepts LEO Pharma’s MAA for delgocitinib cream in chronic hand eczema
Drug Approval | August 21, 2023

EMA accepts LEO Pharma’s MAA for delgocitinib cream in chronic hand eczema

LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment


Honeywell, Recipharm to speed development of inhalers
News | August 18, 2023

Honeywell, Recipharm to speed development of inhalers

Honeywell Solstice Air is a hydrofluoroolefin (HFO) propellant in clinical development today for pMDIs


BASF, Promega and Swiss TPH collaborate to drive research for malaria control
News | August 18, 2023

BASF, Promega and Swiss TPH collaborate to drive research for malaria control

Proteolysis Targeting Chimeras (PROTACs) technology as potential new method for mosquito-borne disease control